Variants of SLC6A4 in depression risk following severe TBI

References

• Bombardier CH, Fann JR, Temkin NR, Esselman PC, Barber J, Dikmen SS. Rates of major depressive disorder and clinical outcomes following traumatic brain injury. Journal of the American Medical Association 2010;303:1938–1945
   PubMed Web of Science ®Google Scholar
• Jorge RE, Robinson RG, Moser D, Tateno A, Crespo-Facorro B, Arndt S. Major depression following traumatic brain injury. Archives of General Psychiatry 2004;61:42–50
   PubMed Web of Science ®Google Scholar
• Gould KR, Ponsford JL, Johnston L, Schönberger M. The nature, frequency and course of psychiatric disorders in the first year after traumatic brain injury: A prospective study. Psychological Medicine 201;FirstView:1–11
   Google Scholar
• Teasdale G, Jennett B. Assessment of coma and impaired consciousness. A practical scale. Lancet 1974;2:81–84
   PubMed Web of Science ®Google Scholar
• Maller JJ, Thomson RHS, Lewis PM, Rose SE, Pannek K, Fitzgerald PB. Traumatic brain injury, major depression, and diffusion tensor imaging: making connections. Brain Research Reviews 201;64:213–240
   Google Scholar
• Jorge RE, Robinson RG, Starkstein SE, Arndt SV. Influence of major depression on 1-year outcome in patients with traumatic brain injury. Journal of Neurosurgery 1994;81:726–733
   PubMed Web of Science ®Google Scholar
• Fann JR, Hart T, Schomer KG. Treatment for depression after traumatic brain injury: A systematic review. Journal of Neurotrauma 2009;26:2383–2402
   PubMed Web of Science ®Google Scholar
• Fann JR, Uomoto JM, Katon WJ. Cognitive improvement with treatment of depression following mild traumatic brain injury. Psychosomatics. 2001;42:48–54
   PubMed Web of Science ®Google Scholar
• Krishnan V, Nestler EJ. The molecular neurobiology of depression. Nature 2008;455:894–902
   PubMed Web of Science ®Google Scholar
• Heils A, Teufel A, Petri S, Stöber G, Riederer P, Bengel D, Lesch KP. Allelic variation of human serotonin transporter gene expression. Journal of Neurochemistry 2002;66:2621–2624
   Google Scholar
• Karg K, Burmeister M, Shedden K, Sen S. The serotonin transporter promoter variant (5-HTTLPR), stress, and depression meta-analysis revisited: evidence of genetic moderation. Archives of General Psychiatry 2011;68:444–454
   PubMed Web of Science ®Google Scholar
• Risch N, Herrell R, Lehner T, Liang K-Y, Eaves L, Hoh J, Griem A, Kovacs M, Ott J, Merikangas KR. Interaction between the serotonin transporter gene (5-HTTLPR), stressful life events, and risk of depression: a meta-analysis. JAMA: The Journal of the American Medical Association 2009;301:2462–2471
   PubMed Web of Science ®Google Scholar
• Hariri AR, Mattay VS, Tessitore A, Kolachana B, Fera F, Goldman D, Egan MF, Weinberger DR. Serotonin transporter genetic variation and the response of the human amygdala. Science 2002;297:400–403
   PubMed Web of Science ®Google Scholar
• Homberg JR, Lesch K-P. Looking on the bright side of serotonin transporter gene variation. Biological Psychiatry 2011;69:513--519
   Google Scholar
• Wendland JR, Martin BJ, Kruse MR, Lesch K-P, Murphy DL. Simultaneous genotyping of four functional loci of human SLC6A4, with a reappraisal of 5-HTTLPR and rs25531. Molecular Psychiatry 2006;11:224–226
   PubMed Web of Science ®Google Scholar
• Zalsman G, Huang Y, Oquendo MA, Burke AK, Hu X, Brent DA, Ellis SP, Goldman D, Mann JJ. Association of a triallelic serotonin transporter gene promoter region (5-HTTLPR) polymorphism with stressful life events and severity of depression. American Journal of Psychiatry 2006;163:1588–1593
   PubMed Web of Science ®Google Scholar
• Ogilvie AD, Battersby S, Bubb VJ, Fink G, Harmar AJ, Goodwim GM, Smith CA. Polymorphism in serotonin transporter gene associated with susceptibility to major depression. Lancet 1996;347:731–733
   PubMed Web of Science ®Google Scholar
• Rees M, Norton N, Jones I, McCandless F, Scourfield J, Holmans P, Moorhead S, Feldman E, Sadler S, Cole T, et al. Association studies of bipolar disorder at the human serotonin transporter gene (hSERT; 5HTT). Molecular Psychiatry 1997;2:398–402
   PubMed Web of Science ®Google Scholar
• Bales JW, Wagner AK, Kline AE, Dixon CE. Persistent cognitive dysfunction after traumatic brain injury: A dopamine hypothesis. Neuroscience and Biobehavioral Reviews 2009;33:981–1003
   PubMed Web of Science ®Google Scholar
• Jorge RE, Robinson RG, Arndt SV, Starkstein SE, Forrester AW, Geisler F. Depression following traumatic brain injury: A 1 year longitudinal study. Journal of Affective Disorders 1993;27:233–243
   PubMed Web of Science ®Google Scholar
• Wozniak G, Georgoulias P, Iliadis C, Valotasiou V, Papadopoulos G, Bagiatis V, Tsougos I, Paterakis KN, Fountas KN. Serotonin and neuron-specific enolase. Neurosurgery Quarterly 2010;20:297–303
   Google Scholar
• Kline A, Yu J, Horváth E, Marion D, Dixon C. The selective 5-HT1A receptor agonist repinotan HCl attenuates histopathology and spatial learning deficits following traumatic brain injury in rats. Neuroscience 2001;106:547–555
   PubMed Web of Science ®Google Scholar
• Kline AE, Yu J, Massucci JL, Zafonte RD, Dixon CE. Protective effects of the 5-HT1A receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin against traumatic brain injury-induced cognitive deficits and neuropathology in adult male rats. Neuroscience Letters 2002;333:179–182
   PubMedGoogle Scholar
• Chan F, Lanctôt KL, Feinstein A, Herrmann N, Strauss J, Sicard T, Kennedy JL, McCullagh S, Rapoport MJ. The serotonin transporter polymorphisms and major depression following traumatic brain injury. Brain Injury 2008;22:471–479
   PubMed Web of Science ®Google Scholar
• Lanctôt KL, Rapoport MJ, Chan F, Rajaram RD, Strauss J, Sicard T, McCullagh S, Feinstein A, Kiss A, Kennedy JL, et al. Genetic predictors of response to treatment with citalopram in depression secondary to traumatic brain injury. Brain Injury 2010;24:959–969
   PubMed Web of Science ®Google Scholar
• Zafonte RD, Cullen N, Lexell J. Serotonin agents in the treatment of acquired brain injury. The Journal of Head Trauma Rehabilitation 2002;17:322
   PubMedGoogle Scholar
• Fann JR, Bombardier CH, Dikmen S, Esselman P, Warms CA, Pelzer E, Rau H, Temkin N. Validity of the Patient Health Questionnaire-9 in assessing depression following traumatic brain injury. The Journal of Head Trauma Rehabilitation 2005;20:501–511
   PubMed Web of Science ®Google Scholar
• Cook KF, Bombardier CH, Bamer AM, Choi SW, Kroenke K, Fann JR. Do somatic and cognitive symptoms of traumatic brain injury confound depression screening? Archives of Physical Medicine and Rehabilitation 2011;92:818–823
   PubMed Web of Science ®Google Scholar
• Edenberg H, Reynolds J. Improved method for detecting the long and short promoter alleles of the serotonin transporter gene HTT (SLC6A4). Psychiatric Genetics 1998;8:193
   PubMedGoogle Scholar
• Gelernter J, Cubells JF, Kidd JR, Pakstis AJ, Kidd KK. Population studies of polymorphisms of the serotonin transporter protein gene. American Journal of Medical Genetics 1999;88:61–66
   PubMed Web of Science ®Google Scholar
• Lotrich FE, Pollock BG, Ferrell RE. Serotonin transporter promoter polymorphism in African Americans: Allele frequencies and implications for treatment. American Journal of Pharmacogenomics: Genomics-Related Research in Drug Development and Clinical Practice 2003;3:145–147
   PubMedGoogle Scholar
• Xie P, Kranzler HR, Poling J, Stein MB, Anton RF, Brady K, Weiss RD, Farrer L, Gelernter J. Interactive effect of stressful life events and the serotonin transporter 5-HTTLPR genotype on posttraumatic stress disorder diagnosis in 2 independent populations. Archives of General Psychiatry 2009;66:1201–1209
   PubMed Web of Science ®Google Scholar
• Hranilovic D, Stefulj J, Schwab S, Borrmann-Hassenbach M, Albus M, Jernej B, Wildenauer D. Serotonin transporter promoter and intron 2 polymorphisms: relationship between allelic variants and gene expression. Biological Psychiatry 2004;55:1090–1094
   PubMed Web of Science ®Google Scholar
• Mak KK, Kong WY, Mak A, Sharma VK, Ho RCM. Polymorphisms of the serotonin transporter gene and post-stroke depression: a meta-analysis. Journal of Neurology, Neurosurgery and Psychiatry 2012;84:322–328
   PubMedGoogle Scholar
• Kenna GA, Roder-Hanna N, Leggio L, Zywiak WH, Clifford J, Edwards S, Kenna JA, Shoaff J, Swift RM. Association of the 5-HTT gene-linked promoter region (5-HTTLPR) polymorphism with psychiatric disorders: review of psychopathology and pharmacotherapy. Pharmacogenomics and Personalized Medicine 2012;5:19–35
   PubMedGoogle Scholar
• Lesch K-P, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S, Benjamin J, Müller CR, Hamer DH, Murphy DL. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 1996;274:1527–1531
   PubMed Web of Science ®Google Scholar
• Little KY, McLaughlin DP, Zhang L, Livermore CS, Dalack GW, McFinton PR, DelProposto ZS, Hill E, Cassin BJ, Watson SJ, et al. Cocaine, ethanol, and genotype effects on human midbrain serotonin transporter binding sites and mRNA levels. The American Journal of Psychiatry 1998;155:207–213
   PubMed Web of Science ®Google Scholar
• Praschak-Rieder N, Kennedy J, Wilson AA, Hussey D, Boovariwala A, Willeit M, Ginovart N, Tharmalingam S, Masellis M, Houle S, et al. Novel 5-HTTLPR allele associates with higher serotonin transporter binding in putamen: a [11C] DASB Positron Emission Tomography Study. Biological Psychiatry 2007;62:327–331
   PubMed Web of Science ®Google Scholar
• Reimold M, Smolka MN, Schumann G, Zimmer A, Wrase J, Mann K, Hu X-Z, Goldman D, Reischl G, Solbach C, et al. Midbrain serotonin transporter binding potential measured with with [11C]DASB is affected by serotonin transporter genotype. Journal of Neural Transmission 2007;114:635–639
   PubMed Web of Science ®Google Scholar
• Parsey RV, Hastings RS, Oquendo MA, Hu X, Goldman D, Huang Y, Simpson N, Arcement J, Huang Y, Ogden RT, et al. Effect of a triallelic functional polymorphism of the serotonin-transporter-linked promoter region on expression of serotonin transporter in the human brain. American Journal of Psychiatry 2006;163:48–51
   PubMed Web of Science ®Google Scholar
• Erritzoe D, Holst K, Frokjaer VG, Licht CL, Kalbitzer J, Nielsen FÅ, Svarer C, Madsen J, Knudsen GM. A nonlinear relationship between cerebral serotonin transporter and 5-HT2A receptor binding: an in vivo molecular imaging study in humans. The Journal of Neuroscience 2010;30:3391–3397
   PubMedGoogle Scholar
• Van Dyck CH, Malison RT, Staley JK, Jacobsen LK, Seibyl JP, Laruelle M, Baldwin RM, Innis RB, Gelernter J. Central serotonin transporter availability measured with [123I]beta-CIT SPECT in relation to serotonin transporter genotype. The American Journal of Psychiatry 2004;161:525–531
   PubMed Web of Science ®Google Scholar
• Ho P-S, Ho KK-J, Huang W-S, Yen C-H, Shih M-C, Shen L-H, Ma K-H, Huang S-Y. Association study of serotonin transporter availability and SLC6A4 gene polymorphisms in patients with major depression. Psychiatry Research: Neuroimaging [Internet]. Available online at: http://www.sciencedirect.com/science/article/pii/S0925492712000832, accessed 10 January 2012
   Google Scholar
• Kobiella A, Reimold M, Ulshofer DE, Ikonomidou VN, Vollmert C, Vollstadt-Klein S, Rietschel M, Reischl G, Heinz A, Smolka MN. How the serotonin transporter 5-HTTLPR polymorphism influences amygdala function: the roles of in vivo serotonin transporter expression and amygdala structure. Translational Psychiatry 2011;1:1–9
   Google Scholar
• Busto R, Dietrich WD, Globus MY-T, Alonso O, Ginsberg MD. Extracellular release of serotonin following fluid-percussion brain injury in rats. Journal of Neurotrauma 1997;14:35–42
   PubMedGoogle Scholar
• Gao W-M, Chadha MS, Kline AE, Clark RSB, Kochanek PM, Dixon CE, Jenkins LW. Immunohistochemical analysis of histone H3 acetylation and methylation–evidence for altered epigenetic signaling following traumatic brain injury in immature rats. Brain Research 2006;1070:31–34
   PubMedGoogle Scholar
• Philibert R, Madan A, Andersen A, Cadoret R, Packer H, Sandhu H. Serotonin transporter mRNA levels are associated with the methylation of an upstream CpG island. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 2007;144B:101–105
   PubMed Web of Science ®Google Scholar
• Van IJzendoorn MH, Caspers K, Bakermans-Kranenburg MJ, Beach SRH, Philibert R. Methylation matters: interaction between methylation density and serotonin transporter genotype predicts unresolved loss or trauma. Biological Psychiatry 2010;68:405–407
   PubMed Web of Science ®Google Scholar
• Bendlin BB, Ries ML, Lazar M, Alexander AL, Dempsey RJ, Rowley HA, Sherman JE, Johnson SC. Longitudinal changes in patients with traumatic brain injury assessed with diffusion-tensor and volumetric imaging. NeuroImage 2008;42:503–514
   PubMed Web of Science ®Google Scholar
• Tate DF, Bigler ED. Fornix and hippocampal atrophy in traumatic brain injury. Learning & memory 2000;7:442–446
   PubMed Web of Science ®Google Scholar
• Frodl T, Meisenzahl EM, Zill P, Baghai T, Rujescu D, Leinsinger G, Bottlender R, Schule C, Zwanzger P, Engel RR, et al. Reduced hippocampal volumes associated with the long variant of the serotonin transporter polymorphism in major depression. Archives of General Psychiatry 2004;61:177–183
   PubMed Web of Science ®Google Scholar
• Frodl T, Koutsouleris N, Bottlender R, Born C, Jager M, Morgenthaler M, Scheuerecker J, Zill P, Baghai T, Schule C, et al. Reduced gray matter brain volumes are associated with variants of the serotonin transporter gene in major depression. Molecular Psychiatry 2008;13:1093–1101
   PubMed Web of Science ®Google Scholar
• Faraone SV, Perlis RH, Doyle AE, Smoller JW, Goralnick JJ, Holmgren MA, Sklar P. Molecular genetics of attention-deficit/hyperactivity disorder. Biological Psychiatry 2005;57:1313–1323
   PubMed Web of Science ®Google Scholar
• Malec JF, Brown AW, Moessner AM, Stump TE, Monahan P. A preliminary model for posttraumatic brain injury depression. Archives of Physical Medicine and Rehabilitation 2010;91:1087–1097
   PubMed Web of Science ®Google Scholar
• Warner-Schmidt JL, Duman RS. Hippocampal neurogenesis: opposing effects of stress and antidepressant treatment. Hippocampus 2006;16:239–249
   PubMed Web of Science ®Google Scholar
• Damberg M. Transcription factor AP-2 and monoaminergic functions in the central nervous system. Journal of Neural Transmission 2005;112:1281–1296
   PubMedGoogle Scholar
• García MA, Vázquez J, Giménez C, Valdivieso F, Zafra F. Transcription factor AP-2 regulates human apolipoprotein E gene expression in astrocytoma cells. The Journal of Neuroscience 1996;16:7550–7556
   PubMedGoogle Scholar
• Kessler RC, Chiu WT, Demler O, Walters EE. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the national comorbidity survey replication. Archives of General Psychiatry 2005;62:617–627
   PubMed Web of Science ®Google Scholar
• Faul M, Xu L, Wald MM, Coronado VG. Traumatic brain injury in the United States: Emergency department visits, hospitalizations and deaths 2002–2006. Atlanta, GA: Centers for Disease Control and Prevention, National Center for Injury Prevention and Control; 2010
   Google Scholar
• Mattson MP, Maudsley S, Martin B. BDNF and 5-HT: A dynamic duo in age-related neuronal plasticity and neurodegenerative disorders. Trends in Neurosciences 2004;27:589–594
   PubMed Web of Science ®Google Scholar